Validation of Death and Dying Distress Scale-Chinese Version and Prevalence of Death Anxiety Among Patients With Advanced Cancer

被引:8
|
作者
Tang, Lili [1 ]
Zhang, Yening [1 ]
Pang, Ying [1 ]
Zhou, Yuhe [1 ]
Li, Jinjiang [1 ]
Song, Lili [1 ]
He, Yi [1 ]
Li, Zimeng [1 ]
Wang, Yan [1 ]
机构
[1] Peking Univ Canc Hosp & Inst, Dept Psychooncol, Minist Educ Beijing, Key Lab Carcinogenesis & Translat Res, Beijing, Peoples R China
来源
FRONTIERS IN PSYCHIATRY | 2021年 / 12卷
关键词
oncology; death anxiety; death and dying distress scale; advanced cancer patients; validation; palliative care; psychology; psychometrics; ITEM RESPONSE THEORY; GERMAN VERSION; RESILIENCE; DEMORALIZATION; DEPRESSION; SYMPTOMS; SURVIVAL;
D O I
10.3389/fpsyt.2021.715756
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Purpose: Death anxiety is commonly experienced by individuals with advanced cancer who have a limited life expectancy. The Death and Dying Distress Scale (DADDS) is a validated measure that was created to capture this experience; but no Chinese version is available to date. We conducted a cross-sectional study to explore the psychometric properties of a Chinese version DADDS (DADDS-C) and address prevalence of death anxiety among patients with advanced cancer. Methods: Patients with advanced cancer were recruited from Peking University Cancer Hospital. Measures administered included: DADDS-C, Patient Health Questionnaire (PHQ-9), General Anxiety Disorder-7(GAD-7), Quality of Life at End of Life in Cancer (QUAL-EC), Functional Assessment of Chronic Illness Therapy-Spiritual Well-Being Scale (FACIT-sp). McDonald's Omega, Cronbach's alpha, Exploratory Factor Analysis and Confirmatory Factor Analysis were used to test DADDS-C's reliability and validity. Logistic regression analysis was used to identify risk factors for death anxiety. Results: Of 300 patients approached, 256 (85%) provided informed consent and completed the questionnaires. Of these participants, 43 (16.8%) had moderate death anxiety based on scores of >= 45 on the DADDS-C. Three factors (feeling shortness of time, dying and death distress, being a burden to others) explained 71.643% of shared variation with factor loadings ranging from 0.629 to 0.822. Cronbach's alpha was 0.939; Omega total was 0.959. DADDS-C had acceptable convergent and discriminant validity. Logistic regression analysis indicated that two factors (better relationship with healthcare providers and preparation for end of life) protected patients from death anxiety. Conclusion: DADDS-C is a valid tool for measuring death anxiety in Chinese patients with advanced cancer. The presence of at least moderate death anxiety in a substantial minority of these patients calls for screening for this symptom and for more routine psychological interventions to alleviate and prevent such distress in this population.
引用
收藏
页数:11
相关论文
共 50 条
  • [11] Validation of the Quality of Dying and Death Questionnaire among the Chinese populations
    Wang, Ying
    Liu, Mandong
    Chan, Wallace Chi Ho
    Zhou, Jing
    Chi, Iris
    PALLIATIVE & SUPPORTIVE CARE, 2021, 19 (06) : 694 - 701
  • [12] Nurses' Involvement in Patients' Dying and Death: Scale Development and Validation
    Kondo, Makiko
    Nagata, Hiroshi
    OMEGA-JOURNAL OF DEATH AND DYING, 2015, 70 (03) : 278 - 300
  • [13] Validation of the Farsi version of the Death Obsession Scale among nurses
    Dadfar, Mahboubeh
    Abdel-Khalek, Ahmed M.
    Lester, David
    INTERNATIONAL JOURNAL OF NURSING SCIENCES, 2018, 5 (02) : 186 - 192
  • [14] Death related anxiety in patients with advanced cancer
    Engelmann, Dorit
    Koranyi, Susan
    Quintero-Garzon, Leonhard
    Scheffold, Katharina
    Philipp, Rebecca
    Schulz-Kindermann, Frank
    Haerter, M.
    Mehnert, Anja
    PSYCHO-ONCOLOGY, 2017, 26 : 65 - 65
  • [15] Determinants of death anxiety in patients with advanced cancer
    Neel, Caroline
    Lo, Chris
    Rydall, Anne
    Hales, Sarah
    Rodin, Gary
    BMJ SUPPORTIVE & PALLIATIVE CARE, 2015, 5 (04) : 373 - 380
  • [16] Psychological adjustment to death anxiety: a qualitative study of Chinese patients with advanced cancer
    Chen, Furong
    Ou, Meijun
    Xia, Wanting
    Xu, Xianghua
    BMJ OPEN, 2024, 14 (03):
  • [17] Psychometric evaluation of the Persian version of the Templer's Death Anxiety Scale in cancer patients
    Soleimani, Mohammad Ali
    Yaghoobzadeh, Ameneh
    Bahrami, Nasim
    Sharif, Saeed Pahlevan
    Nia, Hamid Sharif
    DEATH STUDIES, 2016, 40 (09) : 547 - 557
  • [18] Death talk and relief of death-related distress in patients with advanced cancer
    An, Ekaterina
    Wennberg, Erica
    Nissim, Rinat
    Lo, Christopher
    Hales, Sarah
    Rodin, Gary
    BMJ SUPPORTIVE & PALLIATIVE CARE, 2020, 10 (02)
  • [19] Death anxiety among advanced cancer patients: a cross-sectional survey
    Yang Hong
    Lu Yuhan
    Gu Youhui
    Wang Zhanying
    Zheng Shili
    Hou Xiaoting
    Yu Wenhua
    SUPPORTIVE CARE IN CANCER, 2022, 30 (04) : 3531 - 3539
  • [20] Death anxiety among advanced cancer patients: a cross-sectional survey
    Yang Hong
    Lu Yuhan
    Gu Youhui
    Wang Zhanying
    Zheng Shili
    Hou Xiaoting
    Yu Wenhua
    Supportive Care in Cancer, 2022, 30 : 3531 - 3539